Zobrazeno 1 - 9
of 9
pro vyhledávání: '"En-Shuo Liu"'
Autor:
Wen-Wei Lin, Yun-Chi Lu, Bo-Cheng Huang, Chih-Hung Chuang, Yi-An Cheng, I.-Ju Chen, Hui-Ju Liu, Kai-Wen Ho, Tzu-Yi Liao, En-Shuo Liu, Ting-Yi Wu, Long-Sen Chang, Shih-Ting Hong, Tian-Lu Cheng
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Canakinumab is a fully human monoclonal antibody that specifically neutralizes human interleukin (IL)-1β and has been approved by the US Food and Drug Administration for treating different types of autoinflammatory disorders such as cryopyr
Externí odkaz:
https://doaj.org/article/cbc2120056d34be588820d88d63a8a3e
Autor:
Kai-Wen Ho, I.-J.u Chen, Yi-An Cheng, Tzu-Yi Liao, En-Shuo Liu, Huei-Jen Chen, Yun-Chi Lu, Yu-Cheng Su, Steve R. Roffler, Bo-Cheng Huang, Hui-Ju Liu, Ming-Yii Huang, Chiao-Yun Chen, Tian-Lu Cheng
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-12 (2021)
Abstract Background Tumor-targeted nanoparticles hold great promise as new tools for therapy of liquid cancers. Furthermore, the therapeutic efficacy of nanoparticles can be improved by enhancing the cancer cellular internalization. Methods In this s
Externí odkaz:
https://doaj.org/article/90203a981820425d90aa6193a4e80d5c
Autor:
Yi-An Cheng, Tung-Ho Wu, Yun-Ming Wang, Tian-Lu Cheng, I-Ju Chen, Yun-Chi Lu, Kuo-Hsiang Chuang, Chih-Kuang Wang, Chiao-Yun Chen, Rui-An Lin, Huei-Jen Chen, Tzu-Yi Liao, En-Shuo Liu, Fang-Ming Chen
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract Background Developing a universal strategy to improve the specificity and sensitivity of PEGylated nanoaparticles (PEG-NPs) for assisting in the diagnosis of tumors is important in multimodality imaging. Here, we developed the anti-methoxypo
Externí odkaz:
https://doaj.org/article/a1709e686d1b41b7aed8c1d16fb3348b
Autor:
Wen-Wei Lin, Kai-Wen Ho, Hsiang-Han Su, Tien-Fang Fang, Shey-Cherng Tzou, I-Ju Chen, Yun-Chi Lu, Mu-Shen Chang, Yun-Chen Tsai, En-Shuo Liu, Yu-Cheng Su, Yen-Tseng Wang, Tian-Lu Cheng, Hsin-Kai Huang
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Fibrinogen-like protein 1 (FGL1) was recently identified as a major ligand of lymphocyte-activation gene-3 (LAG-3) on activated T cells and serves as an immune suppressive molecule for regulation of immune homeostasis. However, whether FGL1 has thera
Externí odkaz:
https://doaj.org/article/2f22afbac68e419987c354eef80b6a3e
Autor:
Chiao-Yu Hsiao, Jun-Lun Meng, Jung-Zhe Hong, Xuan-Huong Ly, Meng-Hsuan Lin, Chin-Yuan Chang, Minh-Tram T. Nguyen, Tian-Lu Cheng, Wen-Wei Lin, Pierre-Alain Burnouf, Talal Salem Al-Qaisi, En-Shuo Liu, Yu-Cheng Su
Publikováno v:
Bioconjugate Chemistry. 33:2180-2188
Sensitive quantification of methoxy poly(ethylene glycol) (mPEG)-conjugated therapeutics for pharmacokinetic determination is critical for mPEGylated drug development. However, sensitive measurement of low-molecular-weight (lmw) mPEG compounds remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d144a696e7eefb84565ac899eb24ce2
https://doi.org/10.1021/acs.bioconjchem.2c00416
https://doi.org/10.1021/acs.bioconjchem.2c00416
Autor:
Tian-Lu Cheng, I-Ju Chen, Yun Chi Lu, Yu-Cheng Su, Tzu Yi Liao, Yi An Cheng, Ming-Yii Huang, Kai Wen Ho, Steve R. Roffler, Huei Jen Chen, En Shuo Liu, Chiao Yun Chen, Hui Ju Liu, Bo Cheng Huang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-12 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Tumor-targeted nanoparticles hold great promise as new tools for therapy of liquid cancers. Furthermore, the therapeutic efficacy of nanoparticles can be improved by enhancing the cancer cellular internalization. Methods In this study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14a546a4a84c4bc2a644b0f6f4158f6
https://doaj.org/article/90203a981820425d90aa6193a4e80d5c
https://doaj.org/article/90203a981820425d90aa6193a4e80d5c
Autor:
Yun-Chi Lu, Long-Sen Chang, Tzu-Yi Liao, Chih-Hung Chuang, Shih-Ting Hong, Yi-An Cheng, Ting-Yi Wu, Wen-Wei Lin, En-Shuo Liu, Hui-Ju Liu, Bo-Cheng Huang, Kai-Wen Ho, I. Ju Chen, Tian-Lu Cheng
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Canakinumab is a fully human monoclonal antibody that specifically neutralizes human interleukin (IL)-1β and has been approved by the US Food and Drug Administration for treating different types of autoinflammatory disorders such as cryopyrin-associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5f01b578b60ce8fc086778d3c183286
https://doi.org/10.1038/s41598-021-94298-y
https://doi.org/10.1038/s41598-021-94298-y
Autor:
En-Shuo Liu, Chiao-Yun Chen, I-Ju Chen, Yun-Chi Lu, Huei-Jen Chen, Fang-Ming Chen, Tung-Ho Wu, Yi-An Cheng, Rui-An Lin, Tian-Lu Cheng, Tzu-Yi Liao, Kuo-Hsiang Chuang, Yun-Ming Wang, Chih-Kuang Wang
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-12 (2020)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Developing a universal strategy to improve the specificity and sensitivity of PEGylated nanoaparticles (PEG-NPs) for assisting in the diagnosis of tumors is important in multimodality imaging. Here, we developed the anti-methoxypolyethylen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b1b09f2d8d8f1af92ce1340c6b99d3
https://doi.org/10.1186/s12951-020-00680-9
https://doi.org/10.1186/s12951-020-00680-9
Autor:
Yi-An Cheng, Tung-Ho Wu, Yun-Ming Wang, Cheng, Tian-Lu, I-Ju Chen, Yun-Chi Lu, Kuo-Hsiang Chuang, Chih-Kuang Wang, Chiao-Yun Chen, Lin, Rui-An, Huei-Jen Chen, Tzu-Yi Liao, En-Shuo Liu, Chen, Fang-Ming
Additional file 1: Table S1. The BsAb-conjugation rate of αHER2/PEG-NPs. Table S2. The Characterization of BsAb/mPEG-NPs. Figure S1. Immunogenicity of humanized BsAbs. We cocultured dendritic cells differentiated from human PBMCs with autologous CD4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03318c9bb6f6b2672087b93134f75f82
